Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic review

Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic review

BACKGROUND: Tenofovir disoproxil fumarate (TDF), the oral prodrug of tenofovir (TFV), is advocated in pregnancy for prevention of mother-to-child transmission (PMCT) with failure of hepatitis B immunoglobulin and vaccination. The pharmacokinetics of TDF monotherapy for PMCT-HBV is important if deplo...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Marieke Bierhoff, Elise J. Smolders, Joel Tarning, David M. Burger, Rene Spijker, Marcus J. Rijken, Chaisiri Angkurawaranon, Rose McGready, Nicholas J. White, Francois Nosten, Michèle van Vugt
التنسيق:	دورية
منشور في:	2020
الموضوعات:	Medicine Pharmacology, Toxicology and Pharmaceutics
الوصول للمادة أونلاين:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079203745&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/68022
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis
بواسطة: Marieke Bierhoff, وآخرون
منشور في: (2022)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Temofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Temofovir Disoproxil Fumarate Monotherapy
بواسطة: Vera E. Bukkems, وآخرون
منشور في: (2020)

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2020)

Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine
بواسطة: David V. Glidden, وآخرون
منشور في: (2018)

Pharmacokinetics of Atazanavir/ritonavir among HIV-infected Thai children concomitantly taking tenofovir disoproxil fumarate
بواسطة: Torsak Bunupuradah, وآخرون
منشور في: (2018)

Urine tenofovir concentrations correlate with plasma and relate to tenofovir disoproxil fumarate adherence: A randomized, directly observed pharmacokinetic trial (target study)
بواسطة: Paul K. Drain, وآخرون
منشور في: (2020)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate
بواسطة: Phuphuakrat A.
منشور في: (2023)

Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
بواسطة: Solomon M.M., وآخرون
منشور في: (2014)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
بواسطة: Marc M. Solomon, وآخرون
منشور في: (2018)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
بواسطة: Tavitiya Sudjaritruk, وآخرون
منشور في: (2018)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
بواسطة: Marc M. Solomon, وآخرون
منشور في: (2018)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
بواسطة: Tavitiya Sudjaritruk, وآخرون
منشور في: (2018)

Tenofovir Disoproxil Fumarate (TDF) Prenatal Sebagai Pelengkap Tatalaksana Pencegahan Transmisi Vertikal Virus Hepatitis B
بواسطة: Avianita Dewi Kusumawardhani
منشور في: (2020)

Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitors
بواسطة: Geoffroy Liegeon, وآخرون
منشور في: (2019)

Recovery of renal function after early versus late switching of tenofovir disoproxil fumarate in people living with HIV with renal insufficiency
بواسطة: Supawadee Suppadungsuk, وآخرون
منشور في: (2022)

Recovery of renal function after early versus late switching of tenofovir disoproxil fumarate in people living with HIV with renal insufficiency
بواسطة: Suppadungsuk S.
منشور في: (2023)

Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review
بواسطة: Bagus Setyoboedi, Bagus, وآخرون

Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living with HIV: Week 24 Results from IMPAACT 2014
بواسطة: Melvin A.J.
منشور في: (2023)

Incidence rate and time to occurrence of renal impairment and chronic kidney disease among thai hiv-infected adults with tenofovir disoproxil fumarate use
بواسطة: Jirayu Visuthranukul, وآخرون
منشور في: (2022)

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018)

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018)

Erratum : Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight band dosing(Pediatr Infect Dis J. (2015)34(392-397))
بواسطة: Kulkanya Chokephaibulkit
منشور في: (2018)

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
بواسطة: Alex Carballo-Diéguez, وآخرون
منشور في: (2018)

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
بواسطة: Alex Carballo-Diéguez, وآخرون
منشور في: (2018)

Vitamin D and Calcium Supplement Attenuate Bone Loss among HIVInfected Patients Receiving Tenofovir Disoproxil Fumarate/Emtricitabine/ Efavirenz: An Open-Label, Randomized Controlled Trial
بواسطة: Patawee Boontanondha, وآخرون
منشور في: (2020)

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
بواسطة: Avihingsanon A.
منشور في: (2023)

Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy
بواسطة: Marieke Bierhoff, وآخرون
منشور في: (2020)

Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy
بواسطة: Marieke Bierhoff, وآخرون
منشور في: (2020)

Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: A commentary on challenges of implementation
بواسطة: M. Bierhoff, وآخرون
منشور في: (2020)

Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: A commentary on challenges of implementation
بواسطة: M. Bierhoff, وآخرون
منشور في: (2020)

Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus
بواسطة: Nicolas Salvadori, وآخرون
منشور في: (2019)

Raltegravir 1200 mg once daily vs 400 mg twice daily, with emtricitabine and tenofovir disoproxil fumarate, for previously untreated HIV-1 infection: Week 96 results from ONCEMRK, a randomized, double-blind, noninferiority trial
بواسطة: Pedro Cahn, وآخرون
منشور في: (2019)

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial
بواسطة: Pedro Cahn, وآخرون
منشور في: (2018)

Prevention of mother-to-child transmission of hepatitis B virus: A phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
بواسطة: Jourdain G., وآخرون
منشور في: (2017)

Prevention of mother-to-child transmission of hepatitis B virus: A phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
بواسطة: Gonzague Jourdain, وآخرون
منشور في: (2018)

Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures
بواسطة: Mary Ellen Gilder, وآخرون
منشور في: (2019)